Literature DB >> 21762190

Reversible testosterone-induced azoospermia in a 45-year-old man attending an infertility outpatient clinic.

Z Jan1, M Pfeifer, B Zorn.   

Abstract

A 45-year-old male with azoospermia was presented to us with primary infertility. We found that he had been taking testosterone due to erectile dysfunction. Upon its discontinuation, the normozoospermia was restored. This led to a pregnancy. In men aged 40-50, the diagnostic work up of testosterone deficiency should be in accordance with the current guidelines. Moreover, no testosterone prescription should be made without having inquired about parenthood desires. In men of the reproductive age with recent-onset azoospermia, consider the possibility of an iatrogenic cause, primarily due to the testosterone replacement therapy. The treatment is simple: to discontinue the therapy.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762190     DOI: 10.1111/j.1439-0272.2011.01192.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  4 in total

1.  Testicular morphology in hypogonadotropic hypogonadism after the abuse of anabolic steroids.

Authors:  Armin Alibegović
Journal:  Forensic Sci Med Pathol       Date:  2018-09-03       Impact factor: 2.007

2.  Reversible infertility associated with testosterone therapy for symptomatic hypogonadism in infertile couple.

Authors:  Jeong Kyoon Bang; Jung Jin Lim; Jin Choi; Hyung Jae Won; Tae Ki Yoon; Jae Yup Hong; Dong Soo Park; Seung-Hun Song
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

3.  More attention should be paid to the treatment of male infertility with drugs--testosterone: to use it or not?

Authors:  Hong-Jun Li
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

Review 4.  Empirical medical therapy in idiopathic male infertility: Promise or panacea?

Authors:  Jae Hung Jung; Ju Tae Seo
Journal:  Clin Exp Reprod Med       Date:  2014-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.